Vitamins, Minerals and Supplements (VMS) CDMO Market Insight 2026-2031 - Rising Demand for Dietary Supplements Drives Market Growth
Dublin, Aug. 20, 2026 (GLOBE NEWSWIRE) -- The "Vitamins, Minerals And Supplements (VMS) CDMO - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
The global vitamins, minerals and supplements CDMO market was valued at USD 48.13 billion in 2025 and is projected to increase from USD 52.59 billion in 2026 to USD 83.32 billion by 2031. The market is expected to record a compound annual growth rate of 9.64% during the 2026-2031 forecast period, supported by preventive healthcare trends, product innovation and increased outsourcing by nutrition and consumer health brands.
Preventive Healthcare and Consumer Awareness Drive Demand
Consumers are increasingly purchasing vitamins, minerals and dietary supplements for immune, cognitive, metabolic and healthy-aging support. In the United States, 58.1% of adults used supplements in 2024, compared with 52.3% in 2020, according to the Centers for Disease Control and Prevention. This shift from reactive treatment toward proactive health management is creating sustained demand for specialized formulations and scientifically supported products.
Brands increasingly favor contract development and manufacturing organizations with advanced analytical testing, formulation and regulatory capabilities. Facilities equipped with high-performance liquid chromatography and mass spectrometry systems are better positioned to verify product potency, purity and consistency. CDMOs that can improve ingredient bioavailability and develop condition-specific formulations are also securing premium contracts and longer-term customer relationships.
Outsourcing Reshapes the VMS Manufacturing Market
Pharmaceutical, nutraceutical and consumer health companies are outsourcing more product development, manufacturing and packaging activities to focus on branding, marketing and digital distribution. This strategy allows companies to introduce seasonal products and respond to emerging wellness trends without investing in underutilized production capacity.
Manufacturers offering small production runs, rapid line changeovers and multiple dosage formats can command price premiums of approximately 15% to 20%. At the same time, dependence on outsourced capacity is encouraging brands to establish longer-term supply agreements that help secure production availability during periods of peak demand.
Raw Material Volatility Presents an Ongoing Challenge
Ingredient shortages and fluctuating raw material prices continue to pressure vitamins, minerals and supplements CDMO market margins. Production outages and environmental compliance measures affecting Chinese fermentation facilities have contributed to supply concerns for vitamins B12 and D3. Heavy reliance on China for global vitamin C production also creates exposure to export restrictions, tariffs and geopolitical disruption.
Botanical ingredients face similar challenges. Turmeric prices increased in 2024 following adverse monsoon conditions in India, while ashwagandha supply tightened as sports nutrition demand exceeded cultivation capacity. To reduce disruption risks, CDMOs are holding larger inventories and customers are requesting dual-sourcing provisions. However, these measures can increase working capital requirements and create difficulties for smaller manufacturers with limited supplier networks.
Softgels and Sports Nutrition Lead Segment Growth
Tablets generated 40.09% of market revenue in 2025, retaining the largest dosage-form share because of cost efficiency and established high-speed packaging capabilities. Nevertheless, changing consumer preferences are accelerating demand for more convenient and experiential formats, including softgels, gummies, powders, liquids and shots.
Softgels are projected to achieve a 12.02% CAGR through 2031, making them the fastest-growing dosage form. Their ability to support fat-soluble vitamins, omega-3 oils and bioavailability-focused formulations strengthens their commercial appeal. High production requirements, including specialized encapsulation equipment and controlled manufacturing environments, also limit competition and support stronger margins. Chewable softgels are expanding opportunities in pediatric and consumer-friendly supplement categories.
Dietary supplements accounted for 39.26% of sales in 2025, while sports nutrition is forecast to grow at a 12.89% CAGR through 2031. Demand for protein isolates, collagen peptides and branched-chain amino acids is expanding beyond competitive athletes to include active consumers and older adults focused on preserving muscle health.
Plant-based proteins derived from pea, rice and hemp are gaining attention because of allergen and sustainability considerations. Their formulation challenges, including flavor masking and amino acid optimization, create opportunities for CDMOs with specialized product-development expertise. Premium beauty supplements combining hydrolyzed collagen, vitamin C and hyaluronic acid are also contributing to market expansion.
Regional Vitamins, Minerals and Supplements CDMO Market Outlook
North America held the largest regional market share in 2025, supported by mature retail channels, strong supplement adoption and growing demand for third-party product verification. Certified manufacturing facilities continue to benefit as retailers place greater emphasis on quality assurance, traceability and regulatory compliance. The United States remains the region's principal market, while Canada and Mexico provide additional demand and manufacturing capacity.
Asia-Pacific is expected to deliver the fastest incremental revenue growth. Policy incentives, expanding production capacity, stronger quality standards, rapid urbanization and rising e-commerce penetration are making standardized supplements more accessible to new consumers. India and China are central to this expansion, with regional manufacturers adding advanced production lines to serve domestic and export markets.
Europe remains diverse, with Germany maintaining a pharmacy-oriented market, France showing strong interest in organic and plant-based products, and the United Kingdom facing additional compliance complexity following Brexit. Italy and Spain continue to support demand for Mediterranean-associated nutrients, including omega-3s and polyphenols. Brazil's expanding e-commerce sector and manufacturing incentives in Gulf Cooperation Council countries are creating further opportunities in emerging regional markets.
Rising preventive healthcare spending, outsourced manufacturing and innovation across softgels, sports nutrition and functional formats are expected to sustain global vitamins, minerals and supplements CDMO market growth through 2031. Manufacturers with flexible production, advanced testing, regulatory expertise and resilient ingredient sourcing strategies will be best positioned to capture this expanding demand.
Key Topics Covered
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Consumer Health Awareness and Preventive Healthcare
4.2.2 Growing Outsourcing Trend Among Brands
4.2.3 Rapid adoption of gummy, liquid & other experiential formats
4.2.4 Aging Population & Chronic-disease Specific VMS Demand
4.2.5 Regulatory Tightening Driving Outsourcing to Certified CDMOs
4.2.6 Innovation and Advanced Capabilities
4.3 Market Restraints
4.3.1 Volatile Raw-material Prices & Ingredient Shortages
4.3.2 High Capex for Multi-format Production Lines
4.3.3 Heightened Scrutiny of Label Claims & Novel Ingredients
4.3.4 Intellectual Property and Confidentiality Concern
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porters Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Dosage Form
5.1.1 Tablets
5.1.2 Capsules
5.1.3 Softgels
5.1.4 Gummies
5.1.5 Powders
5.1.6 Liquids & Shots
5.1.7 Others
5.2 By Product Type
5.2.1 Dietary Supplements (Vitamins, Minerals, Herbals)
5.2.2 Functional Foods
5.2.3 Functional Beverages
5.2.4 Sports Nutrition
5.2.5 Beauty / Collagen Supplements
5.2.6 Others
5.3 By Service Type
5.3.1 Product Development & Formulation
5.3.2 Manufacturing & Packaging
5.3.3 Quality Control & Analytical Testing
5.3.4 Regulatory & Compliance Services
5.3.5 Logistics & Fulfilment
5.4 By End-user
5.4.1 Pharmaceutical & Biopharma Companies
5.4.2 Nutraceutical Companies
5.4.3 Consumer Health & Wellness Brands
5.4.4 Others
5.5 By Geography
5.5.1 North America
5.5.1.1 United States
5.5.1.2 Canada
5.5.1.3 Mexico
5.5.2 South America
5.5.2.1 Brazil
5.5.2.2 Argentina
5.5.2.3 Rest of South America
5.5.3 Europe
5.5.3.1 Germany
5.5.3.2 France
5.5.3.3 United Kingdom
5.5.3.4 Italy
5.5.3.5 Spain
5.5.3.6 Rest of Europe
5.5.4 Asia-Pacific
5.5.4.1 China
5.5.4.2 India
5.5.4.3 Japan
5.5.4.4 South Korea
5.5.4.5 Australia
5.5.4.6 Rest of Asia-Pacific
5.5.5 Middle East and Africa
5.5.5.1 GCC
5.5.5.2 South Africa
5.5.5.3 Rest of Middle East and Africa
5.5.6 South America
5.5.6.1 Brazil
5.5.6.2 Argentina
5.5.6.3 Rest of South America
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.3.1 Aenova Holding GmbH
6.3.2 Arizona Nutritional Supplements
6.3.3 Bactolac Pharmaceutical, Inc.
6.3.4 Best Formulations Inc.
6.3.5 Captek Softgel International
6.3.6 GMP Laboratories of America, Inc.
6.3.7 Herbalife Intl. of America
6.3.8 Integrated BioPharma, Inc.
6.3.9 International Vitamin Corporation (IVC)
6.3.10 Ion Labs, Inc.
6.3.11 Lief Labs
6.3.12 Lonza Group AG
6.3.13 Novo Holdings A/S (Catalent Inc.)
6.3.14 NutraScience Labs
6.3.15 Robinson Pharma Inc.
6.3.16 Sirio Pharma Co., Ltd.
6.3.17 Soft Gel Technologies, Inc.
6.3.18 Trividia Manufacturing Solutions Inc.
6.3.19 Vitaquest International LLC
6.3.20 Vit-Best Nutrition
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
For more information about this report visit https://www.researchandmarkets.com/r/oa7ks9
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.